LV12084B - Treatment of periodontal disease with alendronate - Google Patents

Treatment of periodontal disease with alendronate Download PDF

Info

Publication number
LV12084B
LV12084B LVP-98-43A LV980043A LV12084B LV 12084 B LV12084 B LV 12084B LV 980043 A LV980043 A LV 980043A LV 12084 B LV12084 B LV 12084B
Authority
LV
Latvia
Prior art keywords
pharmaceutically acceptable
treatment
alendronate
medicament
periodontal disease
Prior art date
Application number
LVP-98-43A
Other languages
English (en)
Latvian (lv)
Other versions
LV12084A (lv
Inventor
Barry J. GERTZ
Gideon A. Rodan
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of LV12084A publication Critical patent/LV12084A/xx
Publication of LV12084B publication Critical patent/LV12084B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-98-43A 1991-12-17 1998-03-06 Treatment of periodontal disease with alendronate LV12084B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/808,701 US5270365A (en) 1991-12-17 1991-12-17 Prevention and treatment of periodontal disease with alendronate

Publications (2)

Publication Number Publication Date
LV12084A LV12084A (lv) 1998-07-20
LV12084B true LV12084B (en) 1998-11-20

Family

ID=25199466

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-43A LV12084B (en) 1991-12-17 1998-03-06 Treatment of periodontal disease with alendronate

Country Status (22)

Country Link
US (1) US5270365A (cs)
EP (1) EP0617624B1 (cs)
JP (1) JP2825654B2 (cs)
KR (1) KR100258667B1 (cs)
AT (1) ATE150646T1 (cs)
AU (1) AU675417B2 (cs)
CA (1) CA2122498A1 (cs)
CY (1) CY2054B1 (cs)
CZ (1) CZ282902B6 (cs)
DE (1) DE69218624T2 (cs)
DK (1) DK0617624T3 (cs)
ES (1) ES2100519T3 (cs)
GR (1) GR3022951T3 (cs)
HK (1) HK1000114A1 (cs)
HU (1) HU221807B1 (cs)
IL (1) IL104109A (cs)
LV (1) LV12084B (cs)
NO (1) NO306197B1 (cs)
NZ (1) NZ246274A (cs)
SK (1) SK280628B6 (cs)
WO (1) WO1993011774A1 (cs)
ZA (1) ZA929712B (cs)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW237386B (cs) * 1992-04-15 1995-01-01 Ciba Geigy
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
WO1995028145A1 (en) * 1994-04-18 1995-10-26 The Procter & Gamble Company Iontophoretic delivery of bisphosphonates to the alveolar bone
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US6008206A (en) * 1994-09-21 1999-12-28 Merck & Co., Inc. Sodium alendronate preparation for local administration
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
CN1181012A (zh) * 1995-02-17 1998-05-06 麦克公司 减小非椎骨骨折危险的方法
WO1996035407A1 (en) * 1995-05-12 1996-11-14 Merck & Co., Inc. Prevention of tooth loss by the administration of alendronate or its salts
CA2245793A1 (en) * 1996-02-14 1997-08-21 Itzhak Binderman Topical bisphosphonates for prevention of bone resorption
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
TR199900730T2 (xx) * 1996-10-04 1999-07-21 Merck & Co., Inc S�v� alendronat form�lasyonlar�
US5773429A (en) * 1996-12-11 1998-06-30 Fuisz Technologies Ltd. Drug combination for treating calcium loss
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
NZ501807A (en) * 1997-07-22 2003-02-28 Merck & Co Inc Oral administration of a bisphosphonate using a continuous schedule for inhibiting bone resorption
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
US6331533B1 (en) * 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
US6696427B1 (en) * 1998-12-23 2004-02-24 Jomaa Pharmaka Gmbh Use of bisphosphonates for the prevention and treatment of infectious processes
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
US20030216358A1 (en) * 2001-07-05 2003-11-20 Muchmore Douglas Boyer Method for enhancing bone mineral density gain
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
US7960054B2 (en) * 2002-01-10 2011-06-14 Excellatron Solid State Llc Packaged thin film batteries
US20070094865A1 (en) * 2002-01-10 2007-05-03 Ji-Guang Zhang Packaged thin film batteries and methods of packaging thin film batteries
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
CA2480814A1 (en) * 2002-04-05 2003-10-23 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
FR2838339B1 (fr) * 2002-04-12 2005-06-24 Univ Angers Derives poly-phosphonates pour compositions dentifrices
US20040137058A1 (en) * 2002-07-09 2004-07-15 Katdare Ashok V. Effervescent bisphosphonate formulation
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US20060034921A1 (en) * 2004-01-05 2006-02-16 Katdare Ashok V Effervescent bisphosphonate formulation
US20050181043A1 (en) * 2004-02-12 2005-08-18 Indranil Nandi Alendronate salt tablet compositions
US20080070087A1 (en) * 2004-02-20 2008-03-20 Excellatron Solid State, Llc Non-volatile cathodes for lithium oxygen batteries and method of producing same
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
KR100564628B1 (ko) * 2004-06-16 2006-03-28 삼성전자주식회사 스플릿 게이트형 플래쉬 메모리 소자 및 그 제조방법
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
CN101351907B (zh) * 2005-10-11 2010-09-29 埃克塞勒特龙固体公司 制造锂电池的方法
US20070087052A1 (en) * 2005-10-19 2007-04-19 Katdare Ashok V Effervescent bisphosphonate formulation
CN101421865B (zh) 2006-03-10 2012-09-26 埃克塞勒特龙固体公司 空气电池及制造方法
US20090118238A1 (en) * 2007-09-17 2009-05-07 Protia, Llc Deuterium-enriched alendronate
CA2770282A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
RU2449761C1 (ru) * 2011-03-09 2012-05-10 Светлана Минифаритовна Алетдинова Способ лечения хронических апикальных периодонтитов
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US9579360B2 (en) * 2012-06-20 2017-02-28 The Trustees Of The University Of Pennsylvania Methods of treating or preventing periodontitis and diseases associated with periodontitis
RU2713257C1 (ru) * 2019-05-06 2020-02-04 Жанна Владимировна Вечеркина Способ лечения хронического апикального периодонтита

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429963A (en) * 1964-06-09 1969-02-25 Colgate Palmolive Co Dental preparation containing polymeric polyelectrolyte
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4042679A (en) * 1975-11-07 1977-08-16 Colgate-Palmolive Company Antibacterial oral composition
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4440779A (en) * 1981-06-30 1984-04-03 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
ATE64397T1 (de) * 1986-11-21 1991-06-15 Ciba Geigy Ag Aromatisch substituierte azacycloalkylalkandiphosphons|uren.
EP0274346B1 (de) * 1986-11-21 1991-03-06 Ciba-Geigy Ag Neue Substituiertaminomethandiphosphonsäuren
US4973576A (en) * 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
US4816437A (en) * 1987-06-01 1989-03-28 Trustees Of Boston University Methods for inducing general and localized bone apposition in-vivo
EP0317505A1 (de) * 1987-11-13 1989-05-24 Ciba-Geigy Ag Neue Azacycloalkylalkandiphosphonsäuren
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
DE3881659D1 (en) * 1987-12-11 1993-07-15 Ciba Geigy Ag Araliphatylaminoalkandiphosphonsaeuren.
US4877603A (en) * 1987-12-18 1989-10-31 The Procter & Gamble Company Oral compositions
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
GB9008433D0 (en) * 1990-04-12 1990-06-13 Beecham Group Plc Novel compositions
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof

Also Published As

Publication number Publication date
CZ148794A3 (en) 1995-03-15
LV12084A (lv) 1998-07-20
AU3242093A (en) 1993-07-19
JPH07502506A (ja) 1995-03-16
CA2122498A1 (en) 1993-06-24
US5270365A (en) 1993-12-14
EP0617624A1 (en) 1994-10-05
JP2825654B2 (ja) 1998-11-18
IL104109A0 (en) 1993-05-13
HK1000114A1 (en) 1997-12-05
AU675417B2 (en) 1997-02-06
CY2054B1 (en) 1998-04-30
DE69218624D1 (de) 1997-04-30
NO942267L (no) 1994-06-16
NO306197B1 (no) 1999-10-04
EP0617624B1 (en) 1997-03-26
NO942267D0 (no) 1994-06-16
KR940703676A (ko) 1994-12-12
KR100258667B1 (ko) 2000-07-01
CZ282902B6 (cs) 1997-11-12
IL104109A (en) 1997-02-18
HU221807B1 (hu) 2003-01-28
NZ246274A (en) 1997-02-24
HUT68788A (en) 1995-07-28
ATE150646T1 (de) 1997-04-15
ES2100519T3 (es) 1997-06-16
SK72794A3 (en) 1995-04-12
GR3022951T3 (en) 1997-06-30
DK0617624T3 (da) 1997-04-21
HU9401378D0 (en) 1994-08-29
DE69218624T2 (de) 1997-08-07
SK280628B6 (sk) 2000-05-16
ZA929712B (en) 1993-06-14
WO1993011774A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
EP0617624B1 (en) Treatment of periodontal disease with alendronate
Chumbley et al. The effect of indomethacin (an aspirin-like drug) on the rate of orthodontic tooth movement
Kim et al. An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars
AU4541496A (en) Inhibition of the degradation of connective tissue matrix protein components in mammals
HU220764B1 (hu) Eljárás csontreparálás elősegítésére alkalmas gyógyászati készítmények előállítására
US11878031B2 (en) Silicic acids for use in the treatment of periodontitis
CN110678179B (zh) 骨再生剂
HK1000114B (en) Treatment of periodontal disease with alendronate
US6682718B1 (en) Remedies for periodontosis
Jaffin et al. Treatment of juvenile periodontitis patients by control of infection and inflammation: Four case reports
WO2001005403A1 (fr) Medicaments pour soigner les parodontopathies
RU2814391C1 (ru) Способ профилактики кариеса зубов при односеансовой санации полости рта у детей
Nuruzzaman et al. Management of Idiopathic Gingival Fibromatosis in a Child with Autism: A Case Report
EA046983B1 (ru) Кремниевая кислота для применения в лечении периодонтита
Loo Nicotine-induced osteonecrosis. A case report
Salwat et al. AL-AZHAR
MacNeil A cineradiographic study of functional soft tissue changes in Class II, Division 1 malocclusions
Ogidan A longitudinal cephalometric study of the eruption pattern of teeth adjacent to the cleft in subjects with unilateral and bilateral clefts of the lip and palate
JP2001213780A (ja) 歯周病治療用医薬組成物